Ellington Management Group’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,200	Closed	-$209K	–	697
2016 Q2	$209K	Buy	+9,200	New	+$209K	0.29%	135